IMR Press / FBL / Special Issues / 1326790389398929409
Targeting EGFR pathway: from single to combined targeting EGFR pathway
Submission deadline: 31 December 2012
Special Issue Editor
Amalia Azzariti
Senior Scientist, Clinical Experimental Oncology Laboratory, Via Hahnemann, 10 - 70126 Bari - Italy
Interests: 15 publications, - grants, Editor of Frontiers in Bioscience
Keywords
Cell Biology
Molecular Biology
Technology
Therapeutics
Manuscript Submission Information

Manuscripts should be submitted via our online editorial system at https://imr.propub.com by registering and logging in to this website. Once you are registered, click here to start your submission. Manuscripts can be submitted now or up until the deadline. All papers will go through peer-review process. Accepted papers will be published in the journal (as soon as accepted) and meanwhile listed together on the special issue website. Research articles, reviews as well as short communications are preferred. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office to announce on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts will be thoroughly refereed through a double-blind peer-review process. Please visit the Instruction for Authors page before submitting a manuscript. The Article Processing Charge (APC) in this open access journal is 2500 USD. Submitted manuscripts should be well formatted in good English.

Published Paper (4 Papers)
Open Access Article
Influence of polymorphisms on EGFR targeted therapy in non-small-cell lung cancer
Elisa Giovannetti, Lale Erdem, Efnan Olcay, Leticia G Leon, Godefridus J. Peters
Front. Biosci. (Landmark Ed) 2011, 16(1), 116–130; https://doi.org/10.2741/3679
4
Download
7
Citations
8
Views
Open Access Article
EGFR tyrosine kinase inhibitors and multidrug resistance: perspectives
Nicola A Colabufo, Marialessandra Contino, Mauro Niso, Francesco Berardi, ... Roberto Perrone
Front. Biosci. (Landmark Ed) 2011, 16(5), 1811–1823; https://doi.org/10.2741/3823
11
Download
11
Citations
18
Views
Open Access Article

EGFR tyrosine kinases inhibitors in cancer treatment: in vitro and in vivo evidence

Anna Elisa Quatrale, Letizia Porcelli, Nicola Silvestris, Giuseppe Colucci, ... Amalia Azzariti
Front. Biosci. (Landmark Ed) 2011, 16(5), 1962–1972; https://doi.org/10.2741/3833
13
Download
32
Citations
16
Views
Open Access Article
Anti-EGFR monoclonal antibody in cancer treatment: in vitro and in vivo evidence
Anna Elisa Quatrale, Daniela Petriella, Letizia Porcelli, Stefania Tommasi, ... Amalia Azzariti
Front. Biosci. (Landmark Ed) 2011, 16(5), 1973–1985; https://doi.org/10.2741/3834
54
Download
4
Citations
35
Views
Back to top